Oncology and Hematology
1657
Episodes 33-48 of 76
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC
1.00 program creditGhassan K. Abou-Alfa, MD
- MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
1.00 program creditAiwu Ruth He, MD, PhD
- MinuteCE®
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
1.25 program creditsSamuel J. Klempner, MD
Teresa K. Tarrant, MD
Peter E. Newburger, MD
Jolan Walter, MD, PHD
Teresa K. Tarrant, MD
Peter E. Newburger, MD
Jacob R. Bledsoe, MD
Peter E. Newburger, MD
Jolan Walter, MD, PHD
Teresa K. Tarrant, MD
Peter E. Newburger, MD
Yelena Janjigian, MD
Samuel J. Klempner, MD
Yelena Janjigian, MD
Yelena Janjigian, MD
Samuel J. Klempner, MD
Samuel J. Klempner, MD
